EIF4EBP1 and prostate carcinoma: Moreover, EIF4EBP1 and RPS6KB1 showed a positive correlation with the catalytic subunit METTL3 in prostate cancer and contained candidate sites for m6A modifications (Supplementary Excel S6), suggesting m6A involvement in their translation.